P

Provasculon

10 employees

Provasculon develops novel forms of stromal cell-derived factor-1 for the treatment of cardiovascular diseases and diabetic ulcers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2007

Funding rounds raised

Total raised

$6M

from 3 investors over 3 rounds

P

Provasculon raised $1.3M on November 9, 2011

Investors: Broadview Ventures Inc

P

Provasculon raised $6M on March 24, 2008

Investors: Mass General Brigham and Biogen Idec

FAQ